Cytisinicline

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameCytisinicline
Drug Alias NameCytisineTabexDesmoxan
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionMuscle-type nicotinic acetylcholine receptor antagonists
TargetsMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsVapingSmoking CessationTobacco Use Disorder +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPortugal +[9] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesSopharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of ZagrebAchieve Life Sciences IncThe University Of Auckland +[5] 
Inactive CompaniesBoston Medical Center Inc
Active IndicationsVapingSmoking CessationTobacco Use Disorder +[5] 
Inactive IndicationsAlcoholismHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG